جست‌وجوی استاد و پژوهشگر

• Nuclear Medicine
• Radiology
• Molecular Imaging
• +۱۲ مورد دیگر

Orhan K. Öz, M.D., Ph.D., is a Professor of Radiology at UT Southwestern Medical Center and Professor of Biomedical Engineering at the UT Southwestern Graduate School of Biomedical Sciences. He serves as Chief of Nuclear Medicine, Medical Director of Nuclear Medicine at Parkland Memorial Hospital, and Director of the Nuclear Medicine Residency Program. He holds the Wechun Pak Professorship of Bone Physics and the Robert W. Parkey, M.D. Distinguished Professorship in Radiology. B.S. in Biology, Chemistry, and Mathematics – Morehouse College M.S. in Applied Mathematics – Clark Atlanta University M.D. and Ph.D. in Biophysics – Stanford University Residency in Radiology – UT Southwestern Advanced Training in PET – University of California, Los Angeles Dr. Öz's research focuses on imaging pancreatic beta cells , diabetic foot infections , novel imaging probe development , and estrogen regulation of bone metabolism . His work bridges nuclear medicine, molecular imaging, endocrinology, and oncology. He has developed a SPECT/CT-based scoring system for diabetic foot infections, contributing significantly to clinical practice. His recent publications reflect a strong trend in molecular and hybrid imaging , particularly using SPECT/CT and PET for cancer, metabolic bone diseases, and endocrine disorders. The research emphasizes quantitative imaging , biomarker development , and translational applications in diabetes and neuroendocrine tumors. Scientific honors include: Wechun Pak Professorship of Bone Physics Robert W. Parkey, M.D. Distinguished Professorship in Radiology Recognition by peers in RSNA and SNMMI for contributions Dr. Öz is actively involved in academic service, mentoring, and grant-funded research. He has served as Co-Director of the Preclinical Nuclear Imaging Laboratory and the Molecular Imaging Probe Laboratory. He advises on radiation safety as Chief of Radiation Safety at Parkland Health & Hospital System and participates in key institutional and international committees, including the IRB Subcommittee on Human Use of Radiation and the International Society of Clinical Densitometry’s Scientific Advisory Council. He is a dedicated educator and frequently lectures nationally and internationally in countries including Australia, Turkey, and China. His editorial contributions include peer-reviewing for journals such as Bone , Journal of Nuclear Medicine , Endocrine , and PLOS One .

Erik Renströmمشاهده پروفایل

استاد

• Diabetes mellitus
• Pancreatic beta-cell physiology
• Insulin secretion
• +۳ مورد دیگر

Erik Renström is a Professor at Lund University , serving as Vice-chancellor for Diabetes - Islet Pathophysiology within University Management. His research focuses on pancreatic beta-cell function and diabetes mechanisms. Active in the LTH Profile Area: Nanoscience and Semiconductor Technology Principal Investigator at Lund University Diabetes Centre Research interests include: Insulin secretion dynamics Diabetes pathophysiology Aging-related beta-cell dedifferentiation Omics-driven hypothesis generation Mechanosensor proteins (PIEZO1, CaV3.2) Pancreatic islet imaging Recent publications highlight CD59 fusion proteins , CART receptor biology , and PIEZO1 mechanosensors in beta-cell function. Collaborations span Medical and Health Sciences with global partners. Scientific achievements include: Knud Lundbaek Award 2015 Infrastructure contributions include superresolution microscopy at the Department of Clinical Sciences, Malmö.

Tony Hanssonمشاهده پروفایل

پژوهشگر

• Mucosal Immunology
• Celiac Disease
• Type 1 Diabetes
• +۵ مورد دیگر

Tony Hansson is an Affiliated Researcher at Uppsala University’s Department of Women's and Children's Health and serves as Head of Office in the University Administration; Regional Offices; Office of Medicine and Pharmacy . Holding an MD (FM) and associate professorship in mucosal immunology, his work focuses on pediatric inflammation, autoimmune diseases, and biomarker development, particularly for celiac disease and type 1 diabetes. Academic Qualifications: FM, MD, Associate Professor of Mucosal Immunology Dr. Hansson’s research explores the intersection of mucosal immunology, metabolic disorders, and inflammatory responses in children. He has contributed extensively to understanding celiac disease diagnostics, including antibody detection methods and biomarker validation. His recent publications highlight advancements in celiac disease screening, ulcerative colitis monitoring, and autoimmune correlations with type 1 diabetes and Down syndrome. Collaborative projects like U-CAN underscore his role in biobanking and clinical data integration. Tony Hansson’s work spans both clinical and laboratory investigations, emphasizing non-invasive diagnostic tools (e.g., fecal markers, serological tests) and mechanistic studies of immune responses in gastrointestinal and metabolic conditions.

Mark Dickmanمشاهده پروفایل

استاد

• Nucleic Acid Therapeutics
• Oligonucleotide Therapeutics
• mRNA Vaccines/Therapeutics
• +۷ مورد دیگر

Professor Mark Dickman, affiliated with the School of Chemical, Materials and Biological Engineering at the University of Sheffield, is a leading expert in Bioanalytical Science and Engineering . His research focuses on developing advanced analytical techniques for characterizing nucleic acid therapeutics, particularly oligonucleotide and mRNA-based drugs. Industry collaborations include ThermoFisher, AstraZeneca, Syngenta, and RedShift Bio. Academic Background : First Class BSc (Biochemistry/Chemistry), PhD at the Krebs Institute (University of Sheffield). Professional History : Research Scientist at Transgenomic Ltd (1993-2003), then academic staff at the University of Sheffield. Key research areas include: Bioseparations (HPLC, 2D-LC, ion-pair chromatography) Biological Mass Spectrometry for RNA and protein analysis Nucleic Acid Therapeutics (mRNA vaccines, oligonucleotide drugs) CRISPR-Cas Systems and RNA interference His publications (over 40) demonstrate expertise in chromatographic methods, bacterial cell wall analysis, and epigenetic studies. Recent work explores: mRNA critical quality attribute monitoring RNA biocontrol purification Peptidoglycan structural characterization Mass spectrometry-based RNA sequence mapping Professional memberships include the Royal Society of Chemistry and American Society for Mass Spectrometry . He contributes to teaching through the CPE 240 Engineering From Living Systems course.

• Pain Research
• Neuroscience
• Molecular Pharmacology
• +۳ مورد دیگر

Dr. Mohammed A Nassar is a University Teacher and Lecturer at the School of Biosciences, University of Sheffield, UK, holding this position since 2010. His academic background includes a Senior Postdoctoral Fellowship at UCL's Molecular Nociception Group (1999-2009) and a Wellcome Prize Fellowship (1998-99), with postgraduate training at UCL's Wellcome Laboratory for Molecular Pharmacology (1994-1998). His educational journey features: Postgraduate Studies (PhD), University College London, 1994-1998, funded by Wellcome Prize Studentship Dr. Nassar's research centers on molecular changes in primary sensory neurons associated with pathological pain. His laboratory employs molecular biology, cellular biology, and functional assays to investigate how inflammation and nerve injury sensitize neurons, aiming to identify targets for novel analgesic drugs. Key focus areas include sodium channel dynamics (Nav1.7, Nav1.8, Nav1.9) and diabetic neuropathy mechanisms. Analysis of his 15 most recent publications reveals dominant themes in sodium channel pharmacology, nociceptor excitability, and translational pain research. His work bridges molecular mechanisms with drug discovery, particularly in diabetic neuropathy models and compound screening for selective analgesia. His scientific recognition includes: Wellcome Prize Fellowship (1998-99) Wellcome Prize Studentship (1994-1998) Dr. Nassar actively supervises postgraduate research through two key projects: investigating diabetic neuropathy-induced excitability changes in db/db mice and screening compounds for selective nociceptor inhibition. His teaching portfolio spans undergraduate courses including Cell & Molecular Biology, Pharmacological Techniques, and Molecular Physiology of Ion Channels, complemented by a Postgraduate Certificate in Learning and Teaching (FHEA). He leads a research laboratory within the School of Biosciences focused on sensory neuron pathophysiology, utilizing advanced techniques to study pain mechanisms and therapeutic interventions.

Pradip Sahaمشاهده پروفایل

دانشیار

• Biochemistry
• Metabolism
• Diabetes
• +۵ مورد دیگر

Pradip Saha, Ph.D. is an Associate Professor at Baylor College of Medicine , actively contributing to biomedical research for over two decades. Currently serving as Co-Director of the Mouse Metabolism & Phenotyping Core , he specializes in in vivo metabolic characterization of mouse models for diseases like diabetes, obesity, cancer, and neurological disorders. Advanced Training : Baylor College of Medicine (2001), National Institute of Cholera and Enteric Diseases (1998) Degree : Ph.D. in Biochemistry from Calcutta University (1996) Dr. Saha’s research focuses on metabolic disorders, diabetes, obesity, and their intersections with cancer . He developed the Mouse Metabolism Core (MMC) in 2008, providing state-of-the-art metabolic phenotyping services to institutions like MDACC, TMHRI, UTHSC, and MIT. His work emphasizes specialized assays for metabolic parameters and expert interpretation. Key research trends from his publications include: Metabolic regulation in diabetes and obesity Role of nuclear receptors in metabolic diseases Therapeutic targeting of adipose tissue Epigenetic mechanisms in adipogenesis Genetic protection against metabolic syndrome The Mouse Metabolism Core collaborates with the Metabolomics Core to dissect metabolic pathways in cancer and diabetes research. His expertise spans biochemistry, metabolic phenotyping, and translational medicine.

Xin Jiangمشاهده پروفایل

پژوهشگر ارشد

• Structural Biology
• Biochemistry
• Membrane Protein Mechanisms
• +۳ مورد دیگر

Dr. Xin Jiang is a Senior Research Fellow at the School of Biotech & Biomolecular Science, University of New South Wales (UNSW), specializing in structural biology and biochemistry. He investigates membrane protein mechanisms and their therapeutic applications, particularly focusing on malaria and cancer metabolism. PhD in 2017 from Tsinghua University under Prof. Yigong Shi Postdoctoral training at Princeton University (2018) with Prof. Nieng Yan Joined UNSW in 2019 Research interests include: Decoding Plasmodium membrane proteins for antimalarial drug development Exploring lipid/cholesterol biogenesis mechanisms in collaboration with BABS senior lipid researchers Publications highlight expertise in glucose/lactate transporters, the Warburg effect, and transporter inhibition strategies. His work spans structural analysis of the Plasmodium falciparum hexose transporter, monocarboxylate transporters, and dual inhibitors targeting malaria and cancer metabolism.

• Alzheimer's Disease
• Vascular Biology
• Endothelial Cell Biology
• +۶ مورد دیگر

Dr. Ka Ka Ting serves as an Adjunct Lecturer in the Department of Medical Sciences at the University of Sydney's Faculty of Medicine and Health, where she is an active member of the Brain and Mind Centre. Her research bridges vascular biology and neurological disorders, with a primary focus on endothelial dysfunction mechanisms in Alzheimer's disease, cancer, and diabetic complications. Her work centers on blood-brain barrier integrity, cellular senescence, and microRNA-based therapeutics, particularly examining VE-cadherin signaling pathways and vascular leak phenomena. Recent studies demonstrate translational applications including oligonucleotide drugs for diabetic retinopathy and cerebral cavernous malformations, alongside investigations into tumor angiogenesis and immune cell trafficking. Analysis of her 15 most recent publications (2024-2013) reveals consistent emphasis on vascular senescence in neurodegeneration, with growing focus on therapeutic targeting of the SphK1/S1P axis in cancer and miR-27a in vascular disorders. Methodologically, her work integrates mouse disease models, molecular signaling analysis, and translational drug development across oncology and neurology. Dr. Ting has secured competitive funding including the 2021 Philip Bushell Foundation grant for Alzheimer's early treatment strategies and the 2019 NHMRC Ideas Grant on endothelial senescence. She collaborates extensively with Sydney-based researchers like Gamble, Vadas, and Zhao, contributing to interdisciplinary projects at the Brain and Mind Centre that investigate vascular contributions to neurological diseases.

Lefteris Zachariaمشاهده پروفایل

دانشیار

• Pharmacology
• Drug Development
• Estradiol Metabolite Biology
• +۹ مورد دیگر

Lefteris Zacharia is an Associate Professor at the University of Nicosia , School of Life and Health Sciences, Department of Health Sciences. He combines academic expertise with industry experience in pharmacology, drug development, and regulatory affairs. BSc in Biochemistry from Denison University (1998) PhD in Pharmacology from University of Pittsburgh School of Medicine (2002) MBA from Katz Graduate School of Business, University of Pittsburgh (2007) His research focuses on estradiol metabolite biology in Alzheimer’s disease, pre-eclampsia, and ischemia-reperfusion injury, alongside investigating inflammation resolution in cancer and cardiovascular diseases. He also explores peritoneal adhesions and nicotine metabolism inhibition for smoking cessation. Recent publications emphasize animal models for cognitive impairment, adrenergic receptor targeting in neurodegeneration, and in vitro systems for metastatic cancer research. His work bridges translational pharmacology and clinical applications . He has participated in European Union grants as principal investigator and NIH grants as co-investigator, with an h-index of 24 and over 1400 citations.

• Natural Product Isolation
• Medicinal Chemistry
• Drug Development
• +۳ مورد دیگر

Kine Østnes Hansen is an Associate Professor at the Department of Pharmacy , UiT The Arctic University of Norway , specializing in Natural Products and Medicinal Chemistry . Her research focuses on marine natural product isolation, characterization, and translational drug development, with particular emphasis on OMICs analysis of complex biological samples like algal biomass. Key Projects : AlgScaleUP, HOTBIO, CandRAS Teaching : Courses FAR-1302, FAR-3311, FAR-3312, FAR-2302 Spin-off Affiliation : Researcher at KinSea Lead Discovery AS Her recent work in 2025 includes DYRK kinase inhibition for diabetes therapy and discovery of ophiobolin-type sesterterpenes. Earlier studies (2019–2021) explored Arctic bryozoan alkaloids, antimicrobial peptides from ascidians, and novel lipid structures from marine bacteria. Techniques employed span UPLC-HR-MS2 metabolomics , LC-Orbitrap lipidomics , and NMR spectral analysis for structural elucidation of bioactive compounds.

Sean Thatcherمشاهده پروفایل

استادیار

• Abdominal aortic aneurysms
• Atherosclerosis
• Angiotensin converting enzyme-2 (ACE2)
• +۶ مورد دیگر

Sean Thatcher, PhD, is an Assistant Professor at the Lewis Katz School of Medicine, Temple University, specializing in Biomedical Education and Data Science. His research focuses on abdominal aortic aneurysms, atherosclerosis, ACE2 enzyme function, sex differences, and renin-angiotensin system (RAS) mechanisms. PhD in Physiology from Marshall University Post-doctoral training in Pharmacology & Nutritional Sciences at University of Kentucky Key research areas: Sex-specific cardiovascular disease mechanisms ACE2 enzyme's role in hypertension and aneurysms Hybrid educational methodology development Vascular smooth muscle cell dynamics Recent publications highlight work on: Sex chromosome impacts on aortic pathology Estrogen's protective effects in vascular disease ACE2-deficiency models in metabolic disorders Myosin inhibition techniques Scientific recognition: F32 Ruth L. Kirschstein National Research Service Award (2009) Faculty of the Year (University of Kentucky, 2019) Professional memberships: American Physiological Society (APS) American Society for Pharmacology and Experimental Therapeutics (ASPET) American Heart Association (AHA) Society for Sex Differences (OSSD)

• Ophthalmology
• Retinal Surgery
• Vitreoretinal Disease
• +۵ مورد دیگر

Rajeev S. Ramchandran, M.D., M.B.A. is an Associate Professor in the Department of Ophthalmology at the University of Rochester School of Medicine and Dentistry, specializing in Retina & Vitreous Services at the Flaum Eye Institute. He is a board-certified ophthalmologist with extensive clinical experience in retinal surgeries, laser therapy, intravitreal injections, and medical retina care. His research interests span multiple domains including telemedicine applications in ophthalmology, diabetic retinopathy screening protocols, retinal imaging technology, health policy and economics, and international ophthalmology. Dr. Ramchandran has developed significant expertise in implementing teleophthalmology programs to improve diabetic retinopathy surveillance in primary care settings and urban low-income populations. Analysis of his recent publications reveals a strong focus on retinal imaging technology development, teleophthalmology program evaluation, and the intersection of eye care with broader health systems. His work demonstrates consistent contributions to improving access to eye care in rural communities and underserved populations through innovative telemedicine solutions. John M. Brophy Award (2013) Operations Faculty Award (2013) Beta Sigma Gamma Honor Society member (2013) Distinction in Research during medical school (2003) Summa Cum Laude graduate from University of Pennsylvania (1998) Phi Beta Kappa member (1998) Dr. Ramchandran actively contributes to clinical education and has participated in numerous research collaborations across disciplines including oncology, pulmonology, and neuroscience. His laboratory work has included significant contributions to understanding vascular biology, ciliogenesis mechanisms, and molecular pathways in retinal disease. He maintains an active clinical practice serving patients in the Rochester area, Finger Lakes Region, and Western New York.

• Pharmacology and Therapeutics
• Basic Pharmaceutics Sciences
• Analytical Chemistry
• +۴ مورد دیگر

Dr. Sercan Yildirim is an Assistant Professor at Karadeniz Technical University's Faculty of Pharmacy, Department of Basic Pharmaceutical Sciences. He holds a PhD in Analytical Chemistry from Karadeniz Technical University (2020) and an undergraduate degree in Pharmacy from Anadolu University (2014). Education: PhD (2020) and MSc (2014) in Analytical Chemistry. Current Role: Assistant Professor (2020–Present), teaching undergraduate and postgraduate courses in analytical chemistry and pharmaceutical analysis. Research Interests: Spanning Analytical Chemistry Pharmaceutical Analysis Bioanalytical Methods Environmental Drug Monitoring Pharmacology and Therapeutics His work focuses on developing advanced chromatographic and electrochemical techniques for drug analysis, environmental monitoring, and pharmaceutical quality control. Recent Publications highlight innovations in Deep eutectic solvent-based microextraction Lab-in-syringe automation for HPLC Nanomaterials in electroanalytical sensors Pharmaceutical nanoparticle formulation DNA interaction studies of antidepressants Aluminium toxicity in food products Grants & Projects: He has led or contributed to 8 funded projects since 2016, including method development for fluoroquinolone antibiotics and beta-blockers in complex matrices.

• Diabetes
• Obesity
• Endocrinology
• +۴ مورد دیگر

Professor Konstantinos Tsigos is affiliated with the Hellenic Open University, serving in the Department of Nutrition and Metabolism. His academic career spans over three decades, with expertise in diabetes, obesity, and endocrinology. Medical Degree, University of Athens (1982) PhD, University of Manchester Medical School (1991) Specialty in Endocrinology, Hope Hospital, Manchester (1987-1991) Senior Research Fellow, NIH Clinical Center (1991-1995) Research Director, EKEDI, Athens (1996-2005) His research focuses on the pathogenesis and treatment of diabetes and obesity, stress-related cardiometabolic disorders, cytokine effects on endocrine axes, and hormone resistance mechanisms. He has contributed extensively to understanding inflammation's role in metabolic dysregulation and hormone-receptor interactions. Key trends in his publications include molecular endocrinology, obesity management, cytokine dynamics, and clinical guidelines for metabolic disorders. His work bridges basic research (e.g., receptor mutations) and public health applications (e.g., European obesity guidelines).

Britta Svorenمشاهده پروفایل

دانشیار بالینی

• Type 1 Diabetes
• Pediatric Endocrinology
• Diabetes Complications
• +۳ مورد دیگر

Britta Svoren, M.D., serves as Associate Professor of Clinical Pediatrics (Part-Time) in the Department of Endocrinology at the University of Rochester School of Medicine and Dentistry. She is actively affiliated with the University of Rochester Medical Faculty Group (URMFG) and Accountable Health Partners (AHP), providing specialized care for children, adolescents, and young adults with diabetes and endocrine disorders while maintaining a 4.9/5 patient satisfaction rating. Her academic foundation includes: MD from SUNY at Buffalo-School of Medicine & Biomedical Sciences (2000) Comprehensive training at Boston Children's Hospital: Internship (2000-2001), Residency (2001-2003), and Pediatric Endocrinology Fellowship (2003-2006) Dr. Svoren's research program focuses on preventing type 1 diabetes complications while preserving pediatric growth, development, and family functioning. She investigates environmental triggers of pancreatic autoimmunity and leverages continuous glucose monitoring technologies to optimize diabetes management, balancing clinical innovation with family-centered care approaches. Her publication history (2003-2009) reveals consistent emphasis on pediatric diabetes pathophysiology and management, with recurring themes in autoimmune mechanisms, technology integration, and complication prevention across diverse clinical scenarios including vitamin D deficiency, insulin pump durability, and endocrine disruptions from environmental exposures. Her scientific recognition includes: Harvard Medical School Scholars in Medicine Fellowship Award (2007) Eli Lilly and Company Fellowship Research Training Grant (2004) NIH Pediatric Research Loan Repayment Grant (2003-2007) Children's Hospital of Buffalo Prize (2000) Alpha Omega Alpha Honor Society (2000) Dean's List for Academic Excellence (1997-1999) Phi Beta Kappa Honor Society (1994) Dr. Svoren has secured significant research funding through NIH and industry partnerships to advance pediatric diabetes care, with her clinical excellence consistently reflected in patient testimonials praising her thorough explanations, collaborative decision-making, and compassionate approach to complex endocrine conditions in young patients.